Radiofrequency Ablation as an Adjunct to Systemic Chemotherapy for Colorectal Pulmonary Metastases

被引:49
作者
Chua, Terence C. [1 ]
Thornbury, Kelly [1 ]
Saxena, Akshat [1 ]
Liauw, Winston [2 ]
Glenn, Derek [3 ]
Zhao, Jing [1 ]
Morris, David L. [1 ]
机构
[1] Univ New S Wales, Dept Surg, St George Hosp, Kogarah, NSW 2217, Australia
[2] St George Hosp, Canc Care Ctr, Sydney, NSW, Australia
[3] St George Hosp, Dept Radiol, Sydney, NSW, Australia
关键词
colorectal cancer; lung metastases; radiofrequency ablation; cancer metastasis; chemotherapy; PHASE-III; 1ST-LINE TREATMENT; PROGNOSTIC-FACTORS; PLUS OXALIPLATIN; RANDOMIZED-TRIAL; LUNG METASTASES; CANCER; FLUOROURACIL; LEUCOVORIN; RESECTION;
D O I
10.1002/cncr.24952
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Radiofrequency ablation (RFA) is an alternative to local treatment for pulmonary metastases in patients who are nonsurgical candidates. Based on previously documented efficacy of this treatment, the authors retrospectively studied the prognostic factors for long-term survival. METHODS: One hundred patients with unresectable colorectal pulmonary metastases underwent percutaneous RFA. Clinical and treatment variables were collected and evaluated using univariate and multivariate analyses with overall survival as the primary endpoint. RESULTS: At a median follow-up period of 23 (range, 1 to 96) months from the time of RFA treatment, 49 patients have died. The median overall survival after RFA treatment was 36 months and 5-year overall survival rates of 30%. Univariate analyses demonstrated that histopathological grade (p < .001), time to RFA treatment (p = .017), response to treatment (p < .001), repeat RFA treatments (p = .001), presence of extrapulmonary metastases (p < .001), presence of mediastinal lymphadenopathy (p = .007), and adjunct systemic chemotherapy (p < .001) were associated with overall survival. Multivariate analyses demonstrated that response to RFA treatment (p < .001), repeat RFA treatment (p = .002), presence of extrapulmonary metastases (p = .008), and use of adjunct systemic chemotherapy (p = .05) were independent predictors for survival. CONCLUSIONS: Radiofrequency ablation for colorectal pulmonary metastases represents a step forward towards a nonsurgical option of combining systemic and local treatment for metastatic disease and is a safe treatment with a low risk profile. Cancer 2010;116:2106-14. (C) 2010 American Cancer Society.
引用
收藏
页码:2106 / 2114
页数:9
相关论文
共 42 条
[1]   Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: Myth or reality? [J].
Adam, Rene ;
Wicherts, Dennis A. ;
de Haas, Robbert J. ;
Aloia, Thomas ;
Levi, Francis ;
Paule, Bernard ;
Guettier, Catherine ;
Kunstlinger, Francis ;
Delvart, Valerie ;
Azoulay, Daniel ;
Castaing, Denis .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1635-1641
[2]   Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases [J].
Blazer, Dan G., III ;
Kishi, Yoji ;
Maru, Dipen M. ;
Kopetz, Scott ;
Chun, Yun Shin ;
Overman, Michael J. ;
Fogelman, David ;
Eng, Cathy ;
Chang, David Z. ;
Wang, Huamin ;
Zorzi, Daria ;
Ribero, Dario ;
Ellis, Lee M. ;
Glover, Katrina Y. ;
Wolff, Robert A. ;
Curley, Steven A. ;
Abdalla, Eddie K. ;
Vauthey, Jean-Nicolas .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (33) :5344-5351
[3]   Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer [J].
Cassidy, Jim ;
Clarke, Stephen ;
Diaz-Rubio, Eduardo ;
Scheithauer, Werner ;
Figer, Arie ;
Wong, Ralph ;
Koski, Sheryl ;
Lichinitser, Mikhail ;
Yang, Tsai-Shen ;
Rivera, Fernando ;
Couture, Felix ;
Sirzen, Florin ;
Saltz, Leonard .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) :2006-2012
[5]   Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer [J].
Cohen, Steven J. ;
Punt, Cornelis J. A. ;
Iannotti, Nicholas ;
Saidman, Bruce H. ;
Sabbath, Kert D. ;
Gabrail, Nashat Y. ;
Picus, Joel ;
Morse, Michael ;
Mitchell, Edith ;
Miller, M. Craig ;
Doyle, Gerald V. ;
Tissing, Henk ;
Terstappen, Leon W. M. M. ;
Meropol, Neal J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) :3213-3221
[6]   Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: A Multicenter study of the Gruppo Oncologico Dell'Italia Meridionale [J].
Colucci, G ;
Gebbia, V ;
Paoletti, G ;
Giuliani, F ;
Caruso, M ;
Gebbia, N ;
Carteni, G ;
Agostara, B ;
Pezzella, G ;
Manzione, L ;
Borsellino, N ;
Misino, A ;
Romito, S ;
Durini, E ;
Cordio, S ;
Di Seri, M ;
Lopez, M ;
Maiello, E .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :4866-4875
[7]   Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].
de Gramont, A ;
Figer, A ;
Seymour, M ;
Homerin, M ;
Hmissi, A ;
Cassidy, J ;
Boni, C ;
Cortes-Funes, H ;
Cervantes, A ;
Freyer, G ;
Papamichael, D ;
Le Bail, N ;
Louvet, C ;
Hendler, D ;
de Braud, F ;
Wilson, C ;
Morvan, F ;
Bonetti, A .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947
[8]  
Douillard JY, 2000, LANCET, V355, P1372
[9]   Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial [J].
Douillard, JY ;
Cunningham, D ;
Roth, AD ;
Navarro, M ;
James, RD ;
Karasek, P ;
Jandik, P ;
Iveson, T ;
Carmichael, J ;
Alakl, M ;
Gruia, G ;
Awad, L ;
Rougier, P .
LANCET, 2000, 355 (9209) :1041-1047
[10]   Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:: The Gruppo Oncologico Nord Ovest [J].
Falcone, Alfredo ;
Ricci, Sergio ;
Brunetti, Isa ;
Pfanner, Elisabetta ;
Allegrini, Giacomo ;
Barbara, Cecilia ;
Crino, Lucio ;
Benedetti, Giovanni ;
Evangelista, Walter ;
Fanchini, Laura ;
Cortesi, Enrico ;
Picone, Vincenzo ;
Vitello, Stefano ;
Chiara, Silvana ;
Granetto, Cristina ;
Porcile, Gianfranco ;
Fioretto, Luisa ;
Orlandini, Cinzia ;
Andreuccetti, Michele ;
Masi, Gianluca .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1670-1676